Oyindasola Omolara Oyelaran
Affiliations: | 2005 | Harvard University, Cambridge, MA, United States |
Google:
"Oyindasola Oyelaran"Mean distance: 7.73 | S | N | B | C | P |
Parents
Sign in to add mentor| Matthew D. Shair | grad student | 2005 | Harvard | |
| (Toward a syntheses of the ingenol core and cephalostatin 1.) | ||||
| Jeffrey Gildersleeve | post-doc | National Cancer Institute | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Campbell CT, Gulley JL, Oyelaran O, et al. (2014) Humoral response to a viral glycan correlates with survival on PROSTVAC-VF. Proceedings of the National Academy of Sciences of the United States of America. 111: E1749-58 |
| Campbell CT, Gulley JL, Oyelaran O, et al. (2013) Serum antibodies to blood group A predict survival on PROSTVAC-VF. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1290-9 |
| Oyelaran O, Gildersleeve JC. (2010) Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray Proteomics - Clinical Applications. 4: 285-294 |
| Oyelaran O, Gildersleeve JC. (2009) Glycan arrays: recent advances and future challenges Current Opinion in Chemical Biology. 13: 406-413 |
| Oyelaran O, McShane LM, Dodd L, et al. (2009) Profiling human serum antibodies with a carbohydrate antigen microarray Journal of Proteome Research. 8: 4301-4310 |
| Oyelaran O, Li Q, Farnsworth D, et al. (2009) Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies Journal of Proteome Research. 8: 3529-3538 |
| Gildersleeve JC, Oyelaran O, Simpson JT, et al. (2008) Improved procedure for direct coupling of carbohydrates to proteins via reductive amination Bioconjugate Chemistry. 19: 1485-1490 |
| Oyelaran O, Gildersleeve JC. (2007) Application of carbohydrate array technology to antigen discovery and vaccine development Expert Review of Vaccines. 6: 957-969 |